Lonza Group (OTCMKTS:LZAGY) Lifted to “Strong-Buy” at The Goldman Sachs Group

The Goldman Sachs Group upgraded shares of Lonza Group (OTCMKTS:LZAGY) to a strong-buy rating in a report released on Wednesday morning, Zacks.com reports.

Separately, Berenberg Bank raised Lonza Group to a strong-buy rating in a research note on Sunday, June 23rd.

Lonza Group Stock Down 1.7 %

Shares of LZAGY opened at $60.77 on Wednesday. The firm’s 50 day moving average price is $63.96 and its 200 day moving average price is $59.53. Lonza Group has a twelve month low of $34.19 and a twelve month high of $67.00.

About Lonza Group

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substance and drug product manufacturing.